Advicenne S.A. (EPA:ALDVI)
France · Delayed Price · Currency is EUR 1.752
+0.072 (4.29%)
Aug 21, 2026, 5:35 PM CET
Advicenne Market Cap
Advicenne has a market cap or net worth of €25.49 million as of August 21, 2026. Its market cap has increased by 45.08% in one year.
Market Cap
25.49M
Enterprise Value
43.14M
Revenue
6.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.75
ChartMarket Cap Chart
Since December 6, 2017, Advicenne's market cap has decreased from 112.04M to 25.49M, a decrease of -77.25%. That is a compound annual growth rate of -15.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 25.49M | 3.99% |
| Dec 31, 2025 | 24.51M | 1.30% |
| Dec 31, 2024 | 24.20M | -25.97% |
| Dec 29, 2023 | 32.68M | -28.00% |
| Dec 30, 2022 | 45.40M | -51.76% |
| Dec 31, 2021 | 94.11M | 11.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 6, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MaaT Pharma | 59.36M |
| THX Pharma Société Anonyme | 59.05M |
| Fermentalg | 44.86M |
| Nicox | 33.75M |
| GenSight Biologics | 24.67M |
| genOway Société anonyme | 22.59M |
| Aelis Farma | 14.66M |
| Aton | 12.42M |